Global Airway Stent/Lung Stent Market Size, Share, Forecast Report, 2020-2027

Airway stent/lung stent market is growing at a CAGR of 5.8% during the forecast period. The various factors are driving the market growth include the growing prevalence of lung cancer, rising growth in the healthcare industry, increasing prevalence towards the minimally invasive procedure and rising incidence of chronic respiratory diseases. Airway stent is a tube-based device inserted into an airway, this process is known as airway stenting or interventional pulmonary. It relieves airway obstruction owing to the structure which is not suitable for resection and reconstruction. The disorders are caused due to the presence of malignant tumors, extrinsic compression, and post-intubation tracheal injuries. The doctor puts the stents in place using a procedure known as bronchoscopy.

There are two types of airway stents such as silicon tube stents and metallic stents. A metal stent is inserted with enables of the flexible bronchoscope and silicon stents are inserted with the help of a rigid bronchoscope when the patient. The growing adoption of bronchial stents in the treatment of lung cancer and other respiratory diseases is projecting to drive the growth of the airway stent market. However, the availability of alternative treatment and complication regarding stents are projected to hamper the growth of the market.

Lung cancer is treated with the aid of airway stents referred to as unobstructed airways. The other indications of airway stents include thyroid cancer, vascular compression, oesophageal cancer, inflammatory lesions, primary airway tumor, head, and neck tumor and idiopathic benign tracheal stenosis. The choice of the stent depends on the resource availability and type of lesion to be treated in the presence of operators.

Segmental Outlook

The global airway stent/lung stent market is segmented on the basis of type, material, and end-user. Based on type, the market is segmented into laryngeal stents and tracheobronchial stents. The tracheobronchial stent segment has significant market share owing to higher adoption trends in the bronchial and tracheal stents for utilization in the treatment of chronic respiratory diseases. Based on material, the market is segmented into metal stents, silicone stents, and hybrid stents. The metal stent has a significant growth rate during the forecast period attributed to benefit associated with metal stents that include a lower risk of migration, ability to adapt to the twisted airway, ease of insertion and thinner wall as compared to silicone lung stents. Additionally, metallic stents are self-expandable stents owing to which there is a rising preference of metallic stents due to benefits such as the lower risk of stent induced, small size and bronchoscopy procedure.

The hospital segment will be the largest segment by end-user

Based on end-user, the market is segmented into free-standing clinics/ambulatory surgical centers and hospitals. The hospital segment holds the largest share in the airway stent/lung stent market owing to the increasing number of hospitals, the growing healthcare sector in emerging countries such as India and China, and rising cases of lung cancer and chronic respiratory diseases treated in hospitals.

Regional Outlook

The global airway stent/lung stent market is further segmented based on geography including North America, Europe, Asia-Pacific and Rest of the World. North America is expected to hold the largest share attributed to increasing the prevalence of lung diseases and COPD, growing the aging population, growing healthcare expenditure and rising healthcare infrastructure.

Asia-Pacific will augment with the fastest rate in Airway Stent/Lung Stent market

The market in the Asia-Pacific region is expected to grow at the highest CAGR mainly due to increasing incidence of lung cancer and chronic respiratory diseases, increasing per capita income, increasing life expectancy, growing geriatric population, growing private sector hospitals, presence of favorable regulatory environment and availability of low-cost labor.

Market Players Outlook

The key players operating in the airway stent/lung stent market include Boston Scientific Corp., Taewoong Medical Co., Ltd., Micro-Tech Co. Ltd., Novatech SA, Boston Medical Products, Inc., E. Cook Medical, Inc. Fuji Systems Corp., S&G Biotech, Inc., C. R. Bard, Inc., Kapitex Healthcare, Ltd., and Teleflex, Inc.